Tanshinone IIA targeting cell signaling pathways: a plausible paradigm for cancer therapy
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology,General Medicine
Link
https://link.springer.com/content/pdf/10.1007/s43440-023-00507-y.pdf
Reference120 articles.
1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin 2021;71:209–49. https://doi.org/10.3322/caac.21660.
2. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646–74. https://doi.org/10.1016/j.cell.2011.02.013.
3. Dutta S. Natural products: an upcoming therapeutic approach to cancer. Food Chem Toxicol. 2019;120:240–55.
4. Martin GS. Cell signaling and cancer. Cancer Cell 2003;4:167–74. https://doi.org/10.1016/S1535-6108(03)00216-2.
5. Gotwals P, Cameron S, Cipolletta D, Cremasco V, Crystal A, Hewes B, et al. Prospects for combining targeted and conventional cancer therapy with immunotherapy. Nat Rev Cancer. 2017;17:286–301. https://doi.org/10.1038/nrc.2017.17.
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Research progress on the use of Salvia miltiorrhiza Bunge extracts in the treatment of pulmonary diseases;Biomedicine & Pharmacotherapy;2024-10
2. Expression of RIPK1 and FADD are associated with chemosensitivity and survival in head and heck squamous cell carcinoma via tanshinone IIA‐mediated modulation of the RIPK1‐FADD‐Caspase 8 complex;Molecular Carcinogenesis;2024-05-02
3. An Update on Recent Studies Focusing on the Antioxidant Properties of Salvia Species;Antioxidants;2023-12-13
4. Miltiradiene Production by Cytoplasmic Metabolic Engineering in Nicotiana benthamiana;Metabolites;2023-12-06
5. Prospective pharmacological potential of cryptotanshinone in cancer therapy;Pharmacological Research - Modern Chinese Medicine;2023-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3